Wednesday, June 10, 2026

pharma Β· Hemophilia A Β· Hemophilia A or B With Inhibitors

Baxalta Innovations

Baxalta Innovations trial registry β€” 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Illinois, USA HQ
2015 Founded
475 Employees
EMA registrant Type
Company details
Status
Public
HQ
Illinois, USA
Founded
2015
Employees
475
Programs
6
Drugs
12
Patents
1
Intelligence Β· Clinical Trials

Baxalta Innovations clinical trials

Registry index of 6 ClinicalTrials.gov studies linked to Baxalta Innovations programs β€” each row shows trial ID, program name, phase, status, and indication.

Baxalta Innovations trial registry β€” 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for Baxalta Innovations.

  1. 090701 β€” Phase 3

    Clinical update
  2. TAK-755-3002 β€” Phase 3

    Clinical update
  3. 071102 β€” Phase 3

    Clinical update
  4. Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method β€” Phase 3

    Clinical update
  5. BAX855 β€” Phase 3

    Clinical update
  6. TAK-881 β€” Phase 3

    Clinical update

Trial registry

6 studies